||||Page||
|---|---|---|---|---|
|Report ofthe Trustees||1|to|12|
|Independent<br>Examiner's|Report||13||
|Statement ofFinancial|Activities||14||
|Balance Sheet||15|to|16|
|Cash Flow Statement|||17||
|Notes to the Cash Flow|Statement||18||
|Notes to the Financial Statements||19|to|25|
|DetaBed Statement<br>ofFinancial Activities||26|to|27|





## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 



## 

## 



## 

## 

## 

|Publications|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Throughout<br>2022 the BMS continued to add and update|our library ofresources||||including:||||||||
|-The BMS Consensus<br>statement<br>on the management|of estrogen<br>deficiency|||||symptoms,||artbralgia||and|menopause||
|diagnosis<br>in women treated for early breast cancer|||||||||||||
|- The BMSConsensus<br>statement<br>on Non-hormonal-based|treatments for menopausal||||||symptoms||||||
|- The BMSConsensus<br>statement<br>on Prevention<br>and treatment||ofosteoporosis||in|post||menopausal<br>women||||||
|- The BMSConsensus<br>statement<br>on Primary prevention|ofcoronary heart disease|||||in|women||||||
|- The PPMC Resources<br>Toolkit on the BMSwebsite|||||||||||||
|- Testosterone<br>replacementin<br>menopause<br>BMSToolfor Clinicians|||||||||||||
|-HRTpractical prescribing BMSToolfor cliniclans|||||||||||||
|—HRTpreparations<br>and equivalent<br>alternatives<br>BMSToolfor||clinicians|||||||||||
|- Cognitive Behaviour<br>Therapy (CBT)for menopausal<br>symptoms<br>BMS|||Tollfor clinicians||||||||||
|-Induced menopause<br>in women<br>with endometriosis<br>BMSToolfor clinicians|||||||||||||
|-Menopause<br>and the workplace guidance:<br>what to consider BMSToolfor clinicians|||||||||||||
|—HRT IIHCfact sheet|||||||||||||
|—HRT Summary<br>IPHCfact sheet|||||||||||||
|—Osteoporosis<br>IPHCfact sheet|||||||||||||
|—Induced menopause<br>in women with endometri osis —forpattents<br>JFHCfact sheet|||||||||||||
|—Testosterone for women<br>IPHCfactsheet|||||||||||||
|- Contraception for the older woman<br>IITICfact sheet|||||||||||||
|-Breastcancer: Riskfactors IIHCfact sheet|||||||||||||
|-Endometrial<br>ablation<br>IPHCfact sheet|||||||||||||
|-Flbroids<br>IPHCfact sheet|||||||||||||
|-Heavy periods<br>IPHCfact sheet|||||||||||||
|- Vtertne polyps<br>WHCfact sheet|||||||||||||
|-Five new BMSTVvideos:|||||||||||||
|- Sleep, Zoe Schaedel|||||||||||||
|-Testosterone<br>explained,<br>Kalpana Upadhyay|||||||||||||
|-Post cancer treatments,<br>Paula Briggs|||||||||||||
|-Endometriosis,<br>Haitham<br>Hamoda|||||||||||||
|—Progestogens,<br>Nick Panay|||||||||||||
|—Menopause<br>practice<br>standards<br>produced jotntly|by<br>the|British|Menopause||||Society|(BMS), Royal|||College|of|
|Obstetrtcians<br>and<br>Gynaecologists<br>(RCOG), Society for Endocrinology<br>PJE),||||||Faculty of|||Sexual<br>and Reproductive||||
|Health<br>(FSRH), Faculty ofPharmaceutical<br>Medicine|(FPM)|and the|Royal|Pharmaceutical|||||Society (RPS) These|||are|
|heavily based on NICE quality standards<br>but with apractical||aspect.|||||||||||
|- Ajoint position statement<br>on best practice recommendations||for the|care ofmenopausal|||||women has been|||released|by|
|the BMS, RCOG and SIZ.|||||||||||||
|-Ajoint statement<br>was issued by the BMS, RCOG, FSRH and||RCGp on supply|||shortages||||||||
|-Ajoint RCOG BMSGreen Top Guideline:<br>Alternatives|to HRTfor the Management||||||ofSymptoms ofthe Menopause.||||||
|Throughout<br>the year, the society has also produced<br>regular bi-monthly|||updates||on HRT supply||||issues.||||



## 

## 



## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

## 



## 

## 

## 



## 

## 

|||f r he|ment ofFinancial<br>'<br> Year Ended31s<br>D<br>em|ties<br> er2022||
|---|---|---|---|---|---|
|||||31.12,22|31.12,21|
|||||Unrestricted|Total|
|||||fund|funds|
||||Notes||f.|
|INCOME|AND ENDOWMENTS FROM|||||
|Donations|and legacies||2|44,785|17,382|
|Charitable|activities|||||
|Membership|fees|||276,865|196,276|
|Conference|and meetings|||628,772|493,135|
|Miscellaneous<br>income||||11,576|14,938|
|Investment|income|||504|85|
|Total||||~962 502|~721 816|
|EXPENDITURE ON||||||
|Charitable|activities|||||
|Conference|and meetings|||153,278|59,563|
|Publication|costs|||69,184|47,697|
|||||~405 941|313 102|
|Total||||628 403|~420 362|
|NET INCOME||||334,099|301,454|
|RECONCILIATION||OFFUNDS||||
|Total funds|brought<br>forward|||540,906|239,452|
|TOTAL FUNDS CARRIED FORWARD||||~875 005|~540 906|





## 

||British Menu|ocie|||
|---|---|---|---|---|
||~HI|st|||
||31stDecember 2022||||
||||31.12.22|31.12.21|
||||Unrestricted|Total|
||||fund|funds|
||Notes||f.||
|FIXEDASSETS|||||
|Tangible assets<br>Investments|11<br>12||2,037<br>~1632|2,304<br>1632|
||||3,669|3,936|
|CURRENT ASSETS|||||
|Stocks|13||1,980|1,208|
|Debtors|14||87,898|48,026|
|Cash at bank and in hand|||~1027738|741 647|
||||1,117,616|790,881|
|CREDITORS|||||
|Amounts<br>falling due within one year|15||(246,280)|(253,911)|
|NKT CURRENT ASSETS|||~871 336|~536970|
|TOTAL ASSETSLESSCURRENT|||||
|LIABILITIES|||875,005|540,906|
|NET ASSETS|||~875 005|~540 906|
|FUNDS|16||||
|Unrestricted<br>funds|||~875 005|~540 906|
|TOTAL FUNDS|||~875 005|~540 906|





## 

## 



## 

||||Briti<br>M n<br>se Socie|||
|---|---|---|---|---|---|
||||Cash Flow Statement|||
|||f|eYear Ended 31stDece|r 2022||
|||||31.12.22|31.12.21|
||||Notes|||
|Cash flows from operating<br>activities<br>Cash generated<br>from operations||||~286 756|~472 179|
|Net cash provided<br>by operating<br>activities||||286 756|~472 179|
|Cash tlows from investing|activities|||||
|Purchase oftangible fixed assets||||(1,169)|(706)|
|Interest received||||504|85|
|Net cash used in investing|activities|||~665)|621|
|Change in cash and cash|equivalents|in||||
|the reporting<br>period||||286,091|471,558|
|Cash and cash equivalents|at the|||||
|beginning<br>ofthe reporting|period|||~741 647|270 089|
|Cash and cash equivalents|at the end of|||||
|the reporting<br>period||||~1027738|~741 647|





## 

## 

||||Notes to the Cash Flo<br>t<br>n<br>for the Year E<br>I<br>D cern<br>er<br>02|Notes to the Cash Flo<br>t<br>n<br>for the Year E<br>I<br>D cern<br>er<br>02|||
|---|---|---|---|---|---|---|
||RECONCILIATION||OFNET INCOME TO NET CASH FLOW FROM||OPERATING||
||ACTIVITIES||||||
||||||31.12.22|31.12.21|
||||||f,||
||Net income for the|reporting||period (as per the Statement ofFinancial|||
||Activities)||||334,099|301,454|
||Adjustments<br>for:||||||
||Depreciation<br>charges||||1,436|1,708|
||Interest received||||(504)|(85)|
||Increase in stocks||||(772)|(243)|
||(Increase)/decrease<br>(Decrease)/increase|in <br>in|debtors<br> creditors||(39,872)<br>~7631)|28,062<br>~141283|
||Net cash provided|by|operations||~286 756|~472 179|
|2.|ANALYSIS OF CHANGES IN NET FUNDS||||||
|||||At 1.1.22|Cash flow|At 31.12.22|
|||||f.|||
||Net cash||||||
||Cash at bank and in|hand||~741 647|286 091|1 027738|
|||||741 647|286 091|~1027738|
||Total|||741 647|286 091|~1027738|





## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

||f<br>h Y|f<br>h Y|En<br>I tDecember<br>2|022||
|---|---|---|---|---|---|
|2.|DONATIONS<br>AND LEGACIES|||||
|||||31.12.22|31.12.21|
||Donations|||20,397|2,041|
||Gift aid|||~24 388|~15 341|
|||||~44 785|17382|
|3.|INVESTMENT INCOME|||||
|||||31.12.22|31.12.21|
||Deposit account interest|||504|85|
||INCOME FROM CHARITABLE ACTIVITIES|||||
|||||31.12.22|31.12.21|
|||Activity||||
||Membership<br>fees|Membership|fees|276,865|196,276|
||CBTmeeting income|Conference|and meetings|33,475|31,025|
||Annual<br>conference|Conference|and meetings|248,738|160,916|
||Regional meetings|Conference|and meetings||26,980|
||Grants|Conference|and meetings|20,000||
||WHC symposium<br>income|Conference|and meetings|36,400|26,345|
||WHC other income|Conference|and meetings|8,417|7,799|
||PPMC theory courses|Conference|and meetings|203,886|200,608|
||RCOG meeting|Conference|and meetings|44,196|18,977|
||Menopause<br>cafe|Conference|and meetings|33,660|20,485|
||WHC other income|Miscellaneous<br>income|||584|
||Other incoming resources<br>Publication<br>income|Miscellaneous<br>income<br>Miscellaneous<br>income||4,042<br>~7534|4,263<br>~10091|
|||||~917 213|704 349|
||Grants received, included|in the above, are|as follows:|||
|||||31.12.22|31.12.21|
||Mahalo Trust|||~20 000||





## 

## 

## 

## 

|||||||Direct|
|---|---|---|---|---|---|---|
|||||||Costs|
|Conference|and|meetings||||153,278|
|Publication|costs|||||~69 184|
|||||||~222 462|
|SUPPORT|COSTS||||||
||||||Governance||
||||Management|Finance|costs|Totals|
||||||f.||
|Other resources||expended|~388 686|13719|~3536|~405 941|
|NET INCOME/(EXPENDITURE)|||||||
|Net income/(expenditure)|||is stated after charging/(crediting);||||
||||||31.12.22|31.12.21|
|||||||I|
|Depreciation|-|owned assets|||1,436|1,708|
|Other operating||leases|||11247|~ll 000|



## 

## 

## 

## 

## 

|STAFF COSTS||||||
|---|---|---|---|---|---|
|||||31.12.22|31.12.21|
|||||8||
|Wages and salaries||||209,375|162,375|
|Social security costs<br>Other pension costs||||14,383<br>~2841|11,099<br>2 051|
|||||226 599|~175 525|
|The average monthly|number ofemployees|during|the year was as follows:|||
|||||31.12.22|31.12.21|
|Administration||||6|6|





## 

## 

## 

## 

|The number|ofemplo|ye|es<br>whose employee benefits (excluding<br>employer<br>pension c|osts) exceede|d f60,000was:|
|---|---|---|---|---|---|
|||||31.12.22|31.12.21|
|f60,001 - f70,000|||||1|
|f70,001 - $80,000||||1||
|COMPARATIVES||FORTHE STATEMENT OF FINANCIAL ACTIVITIES||||
||||||Unrestricted|
||||||fund|
|INCOME|AND ENDOWMENTS FROM|||||
|Donations|and legacies||||17,382|
|Charitable|activities|||||
|Membership|fees||||196,276|
|Conference|and meetings||||493,135|
|Miscellaneous<br>income|||||14,938|
|Investment|income||||85|
|Total|||||~721 816|
|EXPENDITURE ON||||||
|Charitable|activities|||||
|Conference|and meetings||||59,563|
|Publication|costs||||47,697|
|Other|||||313 102|
|Total|||||~420 362|
|NET INCOME|||||301,454|
|RECONCILIATION|||OF FUNDS|||
|Total funds|brought|forward|||239,452|
|TOTAL FUNDS CARRIED FORWARD|||||~540 906|





## 

## 

||for the Year End|December 202|2|||
|---|---|---|---|---|---|
|11.|TANGIBLE FIXEDASSETS|||||
|||Plant|and|Computer||
|||machinery||equipment|Totals|
|||f.||||
||COST|||||
||At 1stJanuary 2022|9,346||2,845|12,191|
||Additions||125|1044|~1169|
||At 31stDecember 2022|~9471||~3889|1~3360|
||DEPRECIATION|||||
||At 1stJanuary 2022|7,380||2,507|9,887|
||Charge for year|~1143||293|~1436|
||At 31stDecember 2022|~8523||2 800|1~1323|
||NET BOOKVALUE|||||
||At 31stDecember 2022||948|~1089|~2037|
||At 31stDecember 2021|~1966||338|~2304|
|12.|FIXEDASSETINVESTMENTS|||||
||||||Listed|
||||||investments|
||MARKET VALUE|||||
||At 1st January 2022 and|||||
||31stDecember 2022||||~1632|
||NET BOOKVALUE|||||
||At 31stDecember 2022||||~1632|
||At 31stDecember 2021||||1632|





## 


|14.|DEBTORS:||MOUNTS FA|LLI|NG DUE WITHIN ONE Y|EAR|||
|---|---|---|---|---|---|---|---|---|
||||||||31.12.22|31.12.21|
||Trade debtors||||||6,350|8,595|
||Prepayments|and accrued income|||||81 548|~39431|
||||||||~87 898|~48 026|
|15.|CREDITORS: AMOUNTS|||FALLING DUE WITHIN ONE||YEAR|||
||||||||31.12.22|31.12.21|
||||||||f||
||Trade creditors||||||47,928|11,504|
||Accruals and|deferred income|||||~198352|~242 407|
||||||||~246 280|~253 911|
|16.|MOVEMENT||IN FUNDS||||||
||||||||Net||
||||||||movement|At|
|||||||At 1.1.22|in funds|31.12.22|
|||||||||f,|
||Unrestricted|funds|||||||
||General fund|||||540,906|334,099|875,005|
||TOTAL FUNDS|||||~540 906|~334 099|~875 005|
||Net movement||in funds, included||in the above are as follows:||||
|||||||Incoming|Resources|Movement|
|||||||resources|expended|in funds|
|||||||||f.|
||Unrestricted|funds|||||||
||General fund|||||962,502|(628,403)|334,099|
||TOTAL FUNDS|||||~962 502|~628 403|334099|
||Comparatives||for movement|in|funds||||
||||||||Net||
||||||||movement|At|
|||||||At 1.1.21|in funds|31.12.21|
|||||||||f|
||Unrestricted||funds||||||
||General fund|||||239,452|301,454|540,906|
||TOTAL FUNDS|||||~239 452|~301 454|540 906|





## 

## 

## 

## 

|||Incoming|Resources|Movement|
|---|---|---|---|---|
|||resources|expended|in funds<br>f|
|Unrestricted|funds||||
|General fund||721,816|(420,362)|301,454|
|TOTAL FUNDS||~721 816|~420 362)|~301 454|



||||Net||
|---|---|---|---|---|
||||movement|At|
|||At 1.1.21|in funds|31.12.22|
||||6|f|
|Unrestricted|funds||||
|General fund||239,452|635,553|875,005|
|TOTAL FUNDS||~239 452|635 553|~875 005|



|||Incoming|Resources|Movement|
|---|---|---|---|---|
|||resources|expended|in funds|
||||f,||
|Unrestricted|funds||||
|General fund||1,684,318|(1,048,765)|635,553|
|TOTAL FUNDS||1~684 318|(1~048765)|~635 553|



## 



## 

|||Detailed Statement|ofPinancial Activities|||
|---|---|---|---|---|---|
|||for the Year Ende|tDec mber2022|||
|||||31.12.22|31.12.21|
||||||f|
|INCOME AND ENDOWMENTS||||||
|Donations<br>and legacies||||||
|Donations||||20,397|2,041|
|Gift aid||||~24 388|~15341|
|||||44,785|17,382|
|Investment<br>income||||||
|Deposit account interest||||504|85|
|Charitable<br>activities||||||
|CBTmeeting income||||33,475|31,025|
|Annual<br>conference||||248,738|160,916|
|Regional meetings|||||26,980|
|Membership<br>fees||||276,865|196,276|
|Grants||||20,000||
|WHC symposium|income|||36,400|26,345|
|WHC other income||||8,417|8,383|
|PPMC theory courses||||203,886|200,608|
|Other incoming<br>resources, inc. RCOG||meeting||48,238|23,240|
|Menopause<br>cafe||||33,660|20,485|
|Publication<br>income||||~7534|~10 091|
|||||~917213|~704 349|
|Total incoming<br>resources||||962,502|721,816|
|EXPENDITURE||||||
|Charitable<br>activities||||||
|BMSpublication<br>costs||||66,536|47,697|
|Annual<br>conference|costs|||109,124|16,614|
|Regional meetings||||602|4,360|
|CBTmeeting||||5,417|6,107|
|WHC symposium|expenses|||2,557|2,574|
|WHC other costs|||||180|
|PPMC theory courses||||33,568|26,100|
|Menopause<br>Cafe||||2,010|1,890|
|Books for resale||||2 648|1 738|
|||||222,462|107,260|
|Support costs||||||
|Management||||||
|Wages||||209,375|162,375|
|Social security||||14,383|11,099|
|Pensions||||2,841|2,051|
|Rent||||11,247|11,000|
|Carried forward||||237,846|186,525|





## 

||||||B|r<br>hMeno<br>ause So|cle|||
|---|---|---|---|---|---|---|---|---|---|
|||||D|lied|tatement of F'|IA|||
|||||for|the|Year Ended31 tD|m er2022|||
|||||||||31.12.22|31.12.21|
|Management||||||||||
|Brought forward||||||||237,846|186,525|
|Rates and water||||||||773|839|
|Insurance||||||||785|787|
|Light and heat||||||||1,993|1,707|
|Telephone||||||||3,521|3,178|
|Postage and stationery||||||||16,172|12,960|
|Sundries||||||||7,522|4,873|
|Accountancy||||||||14,022|11,516|
|Legal fees|||||||||841|
|Office costs||||||||4,587|2,912|
|Marketing<br>consultancy||||||||47,137|28,447|
|Website costs||||||||25,948|25,050|
|Other marketing||costs||||||21,209|9,087|
|Storage charges||||||||1,160|758|
|Travelling<br>costs<br>ITservices||||||||1,744<br>~4267|340<br>9061|
|||||||||388,686|298,881|
|Finance||||||||||
|Bank charges<br>Depreciation|of|tangible|fixed assets|||||12,283<br>~1436|10,642<br>1 708|
|||||||||13,719|12,350|
|Governance|costs|||||||||
|Trustees'<br>expenses||||||||1,286|121|
|Independent<br>Examiner's|||fees|||||2250|I 750|
|||||||||~3536|1 871|
|Total resources|expended|||||||~628 403|~420 362|
|Net income||||||||~334099|~301 454|



